This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Last revisionBoth sides next revision | ||
research:clinical_trials [2011/07/25 21:03] – [IVIG Trial] kam | research:clinical_trials [2011/07/25 21:03] – [Sialic Acid (Phase 1) Trial] kam | ||
---|---|---|---|
Line 5: | Line 5: | ||
===== Sialic Acid (Phase 1) Trial ===== | ===== Sialic Acid (Phase 1) Trial ===== | ||
- | Ultragenyx Pharmaceutical Announces the Start of a Phase 1 Clinical Trial for Hereditary Inclusion Body Myopathy (HIBM) - also known as Nonaka Myopathy or Distal Myopathy with Rimmed Vacuoles (DMRV) | + | **Ultragenyx Pharmaceutical Announces the Start of a Phase 1 Clinical Trial for Hereditary Inclusion Body Myopathy (HIBM) - also known as Nonaka Myopathy or Distal Myopathy with Rimmed Vacuoles (DMRV)** |
- | (Novato, CA, July 20, 2011) – Ultragenyx Pharmaceutical has announced that recruitment has begun for a first clinical study for HIBM patients. To be eligible, patients need to have their HIBM diagnosis confirmed with a genetic test. This first study is a short study to see how the investigational drug circulates in the body. | + | |
- | “People with this rare disorder previously had no compelling reason to undergo genetic testing to understand their genetic mutation or to obtain a definitive diagnosis, | + | (Novato, CA, July 20, 2011) -- Ultragenyx Pharmaceutical has announced that recruitment has begun for a first clinical study for HIBM patients. |
- | To obtain testing at no cost, patients should contact their doctor and ask them to order sample collection kits from Ultragenyx for testing. * * * * | + | |
- | Contacts: | + | “People with this rare disorder previously had no compelling reason to undergo genetic testing to understand their genetic mutation or to obtain a definitive diagnosis, |
- | To order test collection kit; John Ditton | + | |
- | jditton@ultragenyx.com | + | To obtain testing at no cost, patients should contact their doctor and ask them to order sample collection kits from Ultragenyx for testing. |
- | To learn more about the Clinical Trials; Mari Maurer, RN, BSN | + | * * * * |
- | mmaurer@ultragenyx.com | + | |
- | Phase 1 Trial Site Contacts: | + | Contacts: |
- | Clinilabs, Inc. | + | To order test collection kit; John Ditton\\ |
- | 212-994-4567 | + | jditton@ultragenyx.com |
- | 423 W. 55th Street, 4th Floor | + | To learn more about the Clinical Trials; Mari Maurer, RN, BSN\\ mmaurer@ultragenyx.com |
- | New York, NY 10019 | + | |
- | participate@clinilabs.com | + | Phase 1 Trial Site Contacts: |
- | www.clinilabs.com | + | |
- | West Coast Clinical Trials | + | Clinilabs, Inc.\\ |
- | 714-668-1500 ext 4009 | + | 212-994-4567\\ |
- | 3545 Howard Way, Suite 100 | + | 423 W. 55th Street, 4th Floor\\ |
- | Costa Mesa, Ca. 92626 | + | New York, NY 10019\\ |
- | ptinfo@wcct.com | + | participate@clinilabs.com |
- | www.wcct.com | + | www.clinilabs.com\\ |
- | Ultragenyx PDF Press Release | + | |
- | ux001_cl101_phase_1_online_ad_w_irb_changes_2011jul20_2_.pdf | + | West Coast Clinical Trials\\ |
+ | 714-668-1500 ext 4009\\ | ||
+ | 3545 Howard Way, Suite 100\\ | ||
+ | Costa Mesa, Ca. 92626\\ | ||
+ | ptinfo@wcct.com\\ | ||
+ | www.wcct.com\\ | ||
+ | |||
+ | |||
+ | **Ultragenyx PDF Press Release** \\ | ||
+ | {{:ux001_cl101_phase_1_online_ad_w_irb_changes_2011jul20_2_.pdf|}} | ||
+ | |||
+ | |||
===== IVIG Trial ===== | ===== IVIG Trial ===== |